Advertisement

Comparison of Angiographic and 1-Year Outcomes Between a Long Single Stent and Overlapping Double Stents in Patients With Newer-Generation Drug-Eluting Stents for Long Narrowings

      Although some clinical studies have revealed adverse clinical and angiographic outcomes of early-generation overlapping drug-eluting stents (DES), the safety and efficacy of overlapping newer-generation DES for long narrowings have not been well established. This study aimed to compare angiographic and 1-year clinical outcomes between a long single stent (LSS) and overlapping double stents (ODS) in patients treated with newer-generation DES for similarly long narrowings. We analyzed 8 to 10 months angiographic and 1-year clinical outcomes of 112 lesions of 105 patients with long (30 to 38 mm) narrowings treated with everolimus-eluting stent, a newer-generation DES, using LSS or ODS. We divided our patients into LSS group (46 patients with 49 lesions) and ODS group (59 patients with 63 lesions). As a result, the rates of freedom from major adverse cardiac events (92.9% vs 93.1%, p = 0.91) and target lesion revascularization (94.5% vs 95.1%, p = 0.79) during 1-year follow-up were similar between the 2 groups. There was no stent thrombosis observed between the 2 groups. In conclusion, everolimus-eluting stent provided similar angiographic and 1-year clinical outcomes regardless of overlap status in long narrowings.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Dawkins K.D.
        • Grube E.
        • Guagliumi G.
        • Banning A.P.
        • Zmudka K.
        • Colombo A.
        • Thuesen L.
        • Hauptman K.
        • Marco J.
        • Wijns W.
        • Popma J.J.
        • Koglin J.
        • Russell M.E.
        Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice.
        Circulation. 2005; 112: 3306-3313
        • Holmes Jr., D.R.
        • Leon M.B.
        • Moses J.W.
        • Popma J.J.
        • Cutlip D.
        • Fitzgerald P.J.
        • Brown C.
        • Fischell T.
        • Wong S.C.
        • Midei M.
        • Snead D.
        • Kuntz R.E.
        Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis.
        Circulation. 2004; 109: 634-640
        • Stone G.W.
        • Ellis S.G.
        • Cannon L.
        • Mann J.T.
        • Greenberg J.D.
        • Spriggs D.
        • O'Shaughnessy C.D.
        • DeMaio S.
        • Hall P.
        • Popma J.J.
        • Koglin J.
        • Russell M.E.
        Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial.
        JAMA. 2005; 294: 1215-1223
        • Schampaert E.
        • Moses J.W.
        • Schofer J.
        • Schluter M.
        • Gershlick A.H.
        • Cohen E.A.
        • Palisaitis D.A.
        • Breithardt G.
        • Donohoe D.J.
        • Wang H.
        • Popma J.J.
        • Kuntz R.E.
        • Leon M.B.
        Sirolimus-eluting stents at two years: a pooled analysis of SIRIUS, E-SIRIUS, and C-SIRIUS with emphasis on late revascularizations and stent thromboses.
        Am J Cardiol. 2006; 98: 36-41
        • Farb A.
        • Weber D.K.
        • Kolodgie F.D.
        • Burke A.P.
        • Virmani R.
        Morphological predictors of restenosis after coronary stenting in humans.
        Circulation. 2002; 105: 2974-2980
        • Finn A.V.
        • Kolodgie F.D.
        • Harnek J.
        • Guerrero L.J.
        • Acampado E.
        • Tefera K.
        • Skorija K.
        • Weber D.K.
        • Gold H.K.
        • Virmani R.
        Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents.
        Circulation. 2005; 112: 270-278
        • Doi H.
        • Maehara A.
        • Mintz G.S.
        • Tsujita K.
        • Kubo T.
        • Castellanos C.
        • Liu J.
        • Yang J.
        • Oviedo C.
        • Aoki J.
        • Franklin-Bond T.
        • Dasgupta N.
        • Lansky A.J.
        • Dangas G.D.
        • Stone G.W.
        • Moses J.W.
        • Mehran R.
        • Leon M.B.
        Classification and potential mechanisms of intravascular ultrasound patterns of stent fracture.
        Am J Cardiol. 2009; 103: 818-823
        • Raber L.
        • Juni P.
        • Loffel L.
        • Wandel S.
        • Cook S.
        • Wenaweser P.
        • Togni M.
        • Vogel R.
        • Seiler C.
        • Eberli F.
        • Luscher T.
        • Meier B.
        • Windecker S.
        Impact of stent overlap on angiographic and long-term clinical outcome in patients undergoing drug-eluting stent implantation.
        J Am Coll Cardiol. 2010; 55: 1178-1188
        • Kitabata H.
        • Loh J.P.
        • Pendyala L.K.
        • Badr S.
        • Dvir D.
        • Barbash I.M.
        • Minha S.
        • Torguson R.
        • Chen F.
        • Satler L.F.
        • Suddath W.O.
        • Kent K.M.
        • Pichard A.D.
        • Waksman R.
        Safety and efficacy outcomes of overlapping second-generation everolimus-eluting stents versus first-generation drug-eluting stents.
        Am J Cardiol. 2013; 112: 1093-1098
        • Farooq V.
        • Vranckx P.
        • Mauri L.
        • Cutlip D.E.
        • Belardi J.
        • Silber S.
        • Widimsky P.
        • Leon M.
        • Windecker S.
        • Meredith I.
        • Negoita M.
        • van Leeuwen F.
        • Neumann F.J.
        • Yeung A.C.
        • Garcia-Garcia H.M.
        • Serruys P.W.
        Impact of overlapping newer generation drug-eluting stents on clinical and angiographic outcomes: pooled analysis of five trials from the international Global RESOLUTE Program.
        Heart. 2013; 99: 626-633
        • O'Sullivan C.J.
        • Stefanini G.G.
        • Raber L.
        • Heg D.
        • Taniwaki M.
        • Kalesan B.
        • Pilgrim T.
        • Zanchin T.
        • Moschovitis A.
        • Bullesfeld L.
        • Khattab A.A.
        • Meier B.
        • Wenaweser P.
        • Juni P.
        • Windecker S.
        Impact of stent overlap on long-term clinical outcomes in patients treated with newer-generation drug-eluting stents.
        EuroIntervention. 2014; 9: 1076-1084
        • Cutlip D.E.
        • Windecker S.
        • Mehran R.
        • Boam A.
        • Cohen D.J.
        • van Es G.A.
        • Steg P.G.
        • Morel M.A.
        • Mauri L.
        • Vranckx P.
        • McFadden E.
        • Lansky A.
        • Hamon M.
        • Krucoff M.W.
        • Serruys P.W.
        Clinical end points in coronary stent trials: a case for standardized definitions.
        Circulation. 2007; 115: 2344-2351
        • Windecker S.
        • Remondino A.
        • Eberli F.R.
        • Juni P.
        • Raber L.
        • Wenaweser P.
        • Togni M.
        • Billinger M.
        • Tuller D.
        • Seiler C.
        • Roffi M.
        • Corti R.
        • Sutsch G.
        • Maier W.
        • Luscher T.
        • Hess O.M.
        • Egger M.
        • Meier B.
        Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization.
        N Engl J Med. 2005; 353: 653-662
        • Turgut O.
        • Yilmaz A.
        • Yalta K.
        • Yilmaz B.M.
        • Ozyol A.
        • Kendirlioglu O.
        • Karadas F.
        • Tandogan I.
        Tortuosity of coronary arteries: an indicator for impaired left ventricular relaxation?.
        Int J Cardiovasc Imaging. 2007; 23: 671-677
        • Minutello R.M.
        • Bhagan S.
        • Feldman D.
        • Sharma A.
        • Hong M.K.
        • Wong S.C.
        Angiographic pattern of restenosis following implantation of overlapping sirolimus-eluting (Cypher) stents.
        Am J Cardiol. 2006; 97: 499-501
        • Burzotta F.
        • Siviglia M.
        • Altamura L.
        • Trani C.
        • Leone A.M.
        • Romagnoli E.
        • Mazzari M.A.
        • Mongiardo R.
        • Niccoli G.
        • Brancati M.
        • Biondi-Zoccai G.
        • Rebuzzi A.G.
        • Schiavoni G.
        • Crea F.
        Outcome of overlapping heterogenous drug-eluting stents and of overlapping drug-eluting and bare metal stents.
        Am J Cardiol. 2007; 99: 364-368
        • Ichikawa M.
        • Yutani C.
        • Hayashi T.
        • Nakata T.
        • Iwata A.
        • Lim Y.J.
        • Mishima M.
        Angioscopic findings of delayed healing at sites of sirolimus-eluting stent overlap after 21-month implantation.
        Int J Cardiol. 2008; 129: e10-e11
        • Otake H.
        • Honda Y.
        • Yamasaki M.
        • Tsujino I.
        • Shimohama T.
        • Sakurai R.
        • Hasegawa T.
        • Waseda K.
        • Ako J.
        • Fitzgerald P.J.
        Vascular response to overlapping everolimus-eluting stents. - comparison with paclitaxel-eluting stents.
        Circ J. 2010; 74: 1023-1025
        • Mori N.
        • Nishino M.
        • Nakamura D.
        • Lee Y.
        • Yoshimura T.
        • Taniike M.
        • Makino N.
        • Kato H.
        • Egami Y.
        • Shutta R.
        • Morita H.
        • Tanouchi J.
        • Yamada Y.
        Different neointimal response to overlapping segments between everolimus-eluting stents and sirolimus-eluting stents—optical coherence tomographic study.
        Circulation. 2011; 124: A12546
        • Byrne R.A.
        • Kastrati A.
        • Massberg S.
        • Wieczorek A.
        • Laugwitz K.L.
        • Hadamitzky M.
        • Schulz S.
        • Pache J.
        • Fusaro M.
        • Hausleiter J.
        • Schomig A.
        • Mehilli J.
        Biodegradable polymer versus permanent polymer drug-eluting stents and everolimus- versus sirolimus-eluting stents in patients with coronary artery disease: 3-year outcomes from a randomized clinical trial.
        J Am Coll Cardiol. 2011; 58: 1325-1331
        • Jensen L.O.
        • Thayssen P.
        • Hansen H.S.
        • Christiansen E.H.
        • Tilsted H.H.
        • Krusell L.R.
        • Villadsen A.B.
        • Junker A.
        • Hansen K.N.
        • Kaltoft A.
        • Maeng M.
        • Pedersen K.E.
        • Kristensen S.D.
        • Botker H.E.
        • Ravkilde J.
        • Sanchez R.
        • Aaroe J.
        • Madsen M.
        • Sorensen H.T.
        • Thuesen L.
        • Lassen J.F.
        Randomized comparison of everolimus-eluting and sirolimus-eluting stents in patients treated with percutaneous coronary intervention: the Scandinavian Organization for Randomized Trials with Clinical Outcome IV (SORT OUT IV).
        Circulation. 2012; 125: 1246-1255
        • Kedhi E.
        • Joesoef K.S.
        • McFadden E.
        • Wassing J.
        • van Mieghem C.
        • Goedhart D.
        • Smits P.C.
        Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial.
        Lancet. 2010; 375: 201-209
        • Stone G.W.
        • Rizvi A.
        • Newman W.
        • Mastali K.
        • Wang J.C.
        • Caputo R.
        • Doostzadeh J.
        • Cao S.
        • Simonton C.A.
        • Sudhir K.
        • Lansky A.J.
        • Cutlip D.E.
        • Kereiakes D.J.
        Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease.
        N Engl J Med. 2010; 362: 1663-1674
        • Bangalore S.
        • Kumar S.
        • Fusaro M.
        • Amoroso N.
        • Attubato M.J.
        • Feit F.
        • Bhatt D.L.
        • Slater J.
        Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials.
        Circulation. 2012; 125: 2873-2891
        • Raber L.
        • Juni P.
        • Nuesch E.
        • Kalesan B.
        • Wenaweser P.
        • Moschovitis A.
        • Khattab A.A.
        • Bahlo M.
        • Togni M.
        • Cook S.
        • Vogel R.
        • Seiler C.
        • Meier B.
        • Windecker S.
        Long-term comparison of everolimus-eluting and sirolimus-eluting stents for coronary revascularization.
        J Am Coll Cardiol. 2011; 57: 2143-2151